Product
allo-APZ2-EB
1 clinical trial
1 indication
Clinical trial
An Interventional, Multicenter, Single Arm, Phase I/IIa Clinical Trial to Investigate the Efficacy and Safety of Allo-APZ2-EB on Epidermolysis Bullosa (EB)Status: Completed, Estimated PCD: 2021-11-26